SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000911916-16-000654
Filing Date
2016-09-07
Accepted
2016-09-07 17:59:14
Documents
1
Period of Report
2016-09-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 27198
  Complete submission text file 0000911916-16-000654.txt   28585
Mailing Address 222 THIRD STREET CAMBRIDGE MA 02142
Business Address 222 THIRD STREET CAMBRIDGE MA 02142 781-365-2596
CoLucid Pharmaceuticals, Inc. (Issuer) CIK: 0001348649 (see all company filings)

IRS No.: 203419541 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address
Hogan Linda C. (Reporting) CIK: 0001639972 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37358 | Film No.: 161874381